ViiV’s Tivicay is to become available in Europe in a new dispersible tablet form to treat children living with HIV. The joint venture, majority-owned by GlaxoSmithKline with Pfizer and Shionogi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback